ArticleDiabetes care2001
Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey.
Article in Diabetes care, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a).American journal of preventive cardiology · 2024Article
- Use of Preventive Aspirin Among Older US Adults With and Without Diabetes.JAMA network open · 2021Article
- Confirmation of reported aspirin use in community studies: utility of serum thromboxane B2 measurement.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2014Article
- Aspirin use and knowledge in the community: a population- and health facility based survey for measuring local health system performance.BMC cardiovascular disorders · 2014Article
- Use of antithrombotic agents among U.S. stroke survivors, 2000-2006.American journal of preventive medicine · 2010Article
- Use of aspirin among diabetics in the primary prevention of cardiovascular disease: need for reliable randomized evidence and astute clinical judgment.Journal of general internal medicine · 2009Review
- Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?Preventive medicine · 2008Article
- Prescription of Aspirin for adults with Diabetes.International journal of diabetes in developing countries · 2008Article
- Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain.BMC family practice · 2007Article
- An appraisal of aspirin therapy in diabetes.Current diabetes reports · 2006Article
- Prevalence of antiplatelet therapy in patients with diabetes.Cardiovascular diabetology · 2005Article
- Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.PLoS medicine · 2005Article
- Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?European journal of clinical pharmacology · 2005Article
- Stroke prevention in diabetic and other high cardiovascular risk patients.Current diabetes reports · 2005Review
- Pharmacological strategies to reduce cardiovascular risk in type 2 diabetes mellitus: an update.Drugs · 2005Review
- Management of Diabetes with Coronary Artery Disease.Current treatment options in cardiovascular medicine · 2003Article
- [Use of anti-aggregant drugs in primary and secondary cardiovascular prevention in diabetics in town and country in the León area].Atencion primaria · 2003Article
- The effect of salicylates on insulin sensitivity.The Journal of clinical investigation · 2001Article
- Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic.Open heartArticle
- Lipid lowering targets are easier to attain than those for treatment of hypertension in type 2 diabetes.Irish journal of medical scienceArticle
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSince 1997, the American Diabetes Association has recommended that aspirin therapy be considered for adults with diabetes who have cardiovascular disease (CVD) or CVD risk factors. We examined the prevalence of regular aspirin use among adults in the U.S. with diagnosed diabetes. RESEARCH DESIGN AND
methodsThe Third National Health and Nutrition Examination Survey (1988-1994) used a probability sample of the U.S. population and included an interview, physical examination, and laboratory studies. Among the survey participants were 1,503 adults (age > or =21 years) with self-reported diabetes. We defined regular aspirin use as reported having taken aspirin > or = 15 times in the previous month. CVD conditions were self-reported heart attack and stroke and symptoms of angina and claudication. CVD risk factors included smoking, hypertension, obesity, albuminuria, lipid abnormalities, and family history of heart attack.
resultsAn estimated 27% of adults with diabetes had CVD, and an additional 71% had one or more CVD risk factors. Aspirin was used regularly by 37% of those with CVD and by 13% of those with risk factors only Adjusted odds of regular aspirin use were significantly greater for individuals with CVD than for those with one CVD risk factor (odds ratio [OR] = 4.3); for non-Hispanic whites than for blacks, Mexican-Americans, and others (OR = 2.5); and for individuals age 40-59 years than for those <40 years (OR = 33.3).
conclusionsNearly every adult in the U.S. with diabetes has at least one risk factor for CVD and thus may be considered a potential candidate for aspirin therapy. During 1988-1994, only 20% (95% CI 16-23) took aspirin regularly Major efforts are needed to increase aspirin use.
Indexed as
Identifiers
11213865What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.